St. Jude Medical Shareholders Approve Merger with Abbott

Life Science Investing News

St. Jude Medical shareholders approved the merger agreement under which Abbott (NYSE:ABT) will acquire St. Jude Medical.

St. Jude Medical (NYSE:STJ) announced that, based on the preliminary voting results from St. Jude Medical’s Annual Meeting of Shareholders held earlier today, St.
Jude Medical shareholders approved the merger agreement under which Abbott (NYSE:ABT) will acquire St. Jude Medical.
As quoted in the press release:

Based on preliminary vote results, approximately 99 percent of voting St. Jude Medical shareholders cast their vote in favor of the merger, representing approximately 74 percent of St. Jude Medical’s outstanding stock as of the record date. The final vote results, including the other proposals’ results, will be available on a Form 8-K that St. Jude Medical plans to file with the Securities and Exchange Commission later this week.

Click here for the full press release.

The Conversation (0)
×